A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

NCT04151563 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Carcinoma, Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: nivolumab
BIOLOGICAL: ipilimumab
DRUG: cabozantinib
BIOLOGICAL: docetaxel
BIOLOGICAL: ramucirumab
DRUG: lucitanib

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]
[object Object]
[object Object]